Citation: R. Rubinstein et N. Novitzky, Thrombo-embolic disease - Prevalence of factor V Leiden in the Western Cape, S AFR MED J, 91(5), 2001, pp. 406-406
Authors:
Boogaerts, M
Winston, DJ
Bow, EJ
Garber, G
Reboli, AC
Schwarer, AP
Novitzky, N
Boehme, A
Chwetzoff, E
De Beule, K
Citation: M. Boogaerts et al., Intravenous and oral itraconazole versus intravenous amphotericin B deoxycholate as empirical antifungal therapy for persistent fever in neutropenic patients with cancer who are receiving broad-spectrum antibacterial therapy- A randomized, controlled trial, ANN INT MED, 135(6), 2001, pp. 412-422
Citation: R. Rubinstein et al., Prevalence of Factor V Leiden in three ethnic groups of patients with deepvein thrombosis in the Western Cape province of South Africa, EUR J HAEMA, 65(1), 2000, pp. 78-79
Citation: N. Novitzky et G. Prindull, Myelodysplastic syndromes in children. A critical review of the clinical manifestations and management, AM J HEMAT, 63(4), 2000, pp. 212-222
Authors:
Novitzky, N
Mohamed, R
Finlayson, J
du Toit, C
Citation: N. Novitzky et al., Increased apoptosis of bone marrow cells and preserved proliferative capacity of selected progenitors predict for clinical response to anti-inflammatory therapy in myelodysplastic syndromes, EXP HEMATOL, 28(8), 2000, pp. 941-949
Authors:
Hale, G
Jacobs, P
Wood, L
Fibbe, WE
Barge, R
Novitzky, N
du Toit, C
Abrahams, L
Thomas, V
Bunjes, D
Duncker, C
Wiesneth, M
Selleslag, D
Hidajat, M
Starobinski, M
Bird, P
Waldmann, H
Citation: G. Hale et al., CD52 antibodies for prevention of graft-versus-host disease and graft rejection following transplantation of allogeneic peripheral blood stem cells, BONE MAR TR, 26(1), 2000, pp. 69-76
Citation: P. Roux et N. Novitzky, The Cape Town experience with haematopoietic stem cell transplantation: The paediatric programme, S AFR MED J, 90(8), 2000, pp. 804-811
Authors:
Davison, GM
Novitzky, N
Kline, A
Thomas, V
Abrahams, L
Hale, G
Waldmann, H
Citation: Gm. Davison et al., Immune reconstitution after allogeneic bone marrow transplantation depleted of T cells, TRANSPLANT, 69(7), 2000, pp. 1341-1347
Authors:
Novitzky, N
Rubinstein, R
Hallett, JM
du Toit, CE
Thomas, VL
Citation: N. Novitzky et al., Bone marrow transplantation depleted of T cells followed by repletion withincremental doses of donor lymphocytes for relapsing patients with chronicmyeloid leukemia - A therapeutic strategy, TRANSPLANT, 69(7), 2000, pp. 1358-1363
Citation: N. Novitzky et P. Jacobs, In aplastic anemia progenitor cells have a reduced sensitivity to the effects of growth factors, EUR J HAEMA, 63(3), 1999, pp. 141-148
Citation: N. Novitzky et al., Cryopreservation of the bone marrow from patients with acute myeloid leukaemia leads to functional abnormalities, EUR J HAEMA, 62(2), 1999, pp. 83-89
Citation: C. Du Toit et N. Novitzky, GVL and GVHD following the infusion of a limited number of donor CD3 cellsin the therapy of leukaemia relapse after bone marrow transplantation, EUR J HAEMA, 62(1), 1999, pp. 68-69
Authors:
Novitzky, N
Thomas, V
Hale, G
Waldmann, H
Citation: N. Novitzky et al., Ex vivo depletion of T cells from bone marrow grafts with CAMPATH-1 in acute leukemia - Graft-versus-host disease and graft-versus-leukemia effect, TRANSPLANT, 67(4), 1999, pp. 620-626
Citation: C. Du Toit et N. Novitzky, Multiple myeloma: Infusions of low doses of donor lymphocytes are also effective in reversing disease recurrence after bone marrow transplantation, BR J HAEM, 103(4), 1998, pp. 1210-1211